KILELE Health shared a post on LinkedIn:
“The ACHA iECHO special engagement series continues!
This June, we focus on a critical milestone in Cervical Cancer prevention and elimination; the newly released WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions.
As countries across Africa accelerate efforts towards Cervical Cancer elimination targets, understanding this guideline is essential for strengthening advocacy, improving policy implementation, and advancing equitable access to cervical cancer services.
Join us as we unpack what it means for Africa and explore how it can be translated into stronger advocacy, policy implementation, community engagement, and equitable access to screening and treatment services.
Topic: Understanding WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions
24th June 2026
3:30–5:00 PM EAT
Register in the link, as we will explore:
- Key recommendations from the guideline
- The role of HPV DNA genotyping and risk-based screening approaches
- Implications for national cervical cancer programmes
- Opportunities for advocacy and policy uptake
- Strategies for improving awareness, access, and equitable service delivery.”
Other articles from KILELE Health on OncoDaily.